CompuMed (OTCMKTS:CMPD) Shares Up 0.2% – Time to Buy?

CompuMed Inc. (OTCMKTS:CMPDGet Free Report) was up 0.2% on Wednesday . The stock traded as high as $6.20 and last traded at $6.20. Approximately 950 shares changed hands during mid-day trading, an increase of 72% from the average daily volume of 553 shares. The stock had previously closed at $6.19.

CompuMed Price Performance

The company has a quick ratio of 2.34, a current ratio of 2.37 and a debt-to-equity ratio of 0.12. The firm has a market cap of $8.25 million, a PE ratio of -41.33 and a beta of -0.47. The stock has a 50 day moving average price of $6.41 and a two-hundred day moving average price of $5.52.

CompuMed (OTCMKTS:CMPDGet Free Report) last announced its quarterly earnings data on Monday, May 11th. The company reported ($0.06) EPS for the quarter. The company had revenue of $2.03 million during the quarter. CompuMed had a negative net margin of 2.51% and a negative return on equity of 6.47%.

CompuMed Company Profile

(Get Free Report)

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

Featured Stories

Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.